Takeshi Kishida - Concepedia

Author

Takeshi Kishida

Also Known As

Kishida Takeshi, Masatoshi Eto, T Kishida, T. Kishida, T., Kishida, TAKESHI KISHIDA, Takeru Kishida, Takeshi KISHIDA, Takeshi Kishida

278

Publications

8.9K

Citations

H-Index

Concepts

All Affiliations

Yokohama City University Kanagawa Prefectural Hospital Organization Kanagawa Cancer Center University of Birmingham Yokosuka Kyosai Hospital

About

Takeshi Kishida is an author at Yokohama City University specializing in medicine, pathology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	31	5.2K
2	Engineering	5	5	429
3	Health Sciences	3	3	116
4	Natural Sciences	2	2	159
5	Public Health	2	2	544

Takeshi Kishida

Publications

8.3K

Citations

H-Index

Page 1

	Year	Citations
Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas Laura S. Schmidt, Fuh-Mei Duh, Fan Chen, Nature Genetics Papillary Renal CarcinomasSomatic VariantSomatic MutationsGenitourinary CancerOncogenic Agent	1997	1.5K
Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: Correlations with phenotype Fan Chen, Takeshi Kishida, Masahiro Yao, Human Mutation GeneticsPathologyDisease Gene IdentificationTumor BiologyClinical Genetics	1995	562
Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan Berton Zbar, Takeshi Kishida, Fan Chen, Human Mutation GeneticsGenetic EpidemiologyPathologyMolecular GeneticsGermline Genetics	1996	502
Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Taro Shuin, Keiichi Kondo, Soichiro Torigoe, PubMed Renal PathologyPathologyTumor BiologyCarcinomaGenitourinary Cancer	1994	473
Activating mutations for the Met tyrosine kinase receptor in human cancer Michael Jeffers, Laura S. Schmidt, Noboru Nakaigawa, Proceedings of the National Academy of Sciences Tumor BiologyRadiation OncologySignal TransductionPapillary Renal CarcinomaMet Mutants	1997	440
State of the art in deep mixing technology. Part III:geomaterial characterization Ali Porbaha, Satoru Shibuya, Takeshi Kishida Proceedings of the Institution of Civil Engineers - Ground Improvement EngineeringPart IiiSoil MechanicsMechanical EngineeringSoil Mechanic	2000	236
Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma. C. O. Morrissey, Alonso Martínez, Malgorzata Zatyka, PubMed Epigenetic InactivationPathologyCc-rcc Cell LinesCancer BiologyEpigenetics	2001	200
Comprehensive mutational analysis of the <i>VHL</i> gene in sporadic renal cell carcinoma: Relationship to clinicopathological parameters Keiichi Kondo, Masahiro Yao, Minoru Yoshida, Genes Chromosomes and Cancer	2002	194
Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma Mark R. Morris, Christopher J. Ricketts, Dean Gentle, Oncogene UrologyGenitourinary CancerEpigenetic ChangeEpigenomicsCancer Genomics	2010	194
Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect Hiltrud Brauch, Takeshi Kishida, Damjan Glavač, Human Genetics Von Hippel-lindauPathologyBlack Forest RegionFounder Effect	1995	181

Page 1